维普中文期刊产品整合服务
36篇 您的检索式:作者名="Surmont"
    题名 作者 年代 出处 被引量
1Stage m A-N2 NSCLC:a review of its treatment approaches and future developments显示文摘van Meerbeeck JP Surmont VF 2009Lung Cancer2009,65,3:1
2Management of recurrent malignant pleural effusions with a chronic indwelling pleural catheter显示文摘van den Toorn L M Schaap E Surmont V F 2005Lung Cancer2005,,50:1
3A double-blind, ran domized, placebo-controlled phase Ⅲ intergroup study of gefitinib(G) in patients (pts) with advanced NSCLC, non-progressing after first-line platinum-based chemotherapy(EORTC 08021-ILCPO1/O3)显示文摘Gaafar RW Surmont V Scagliotti G 2010J Clin Oncol2010,28,15:1
4Glueonate-containing intravenous solutions: another cause of false-positive galactomannan assay reactivity 显示文摘Surmont I Stockman W 2007J Clin Microbiol2007,45,:1
5Management of recurrent malignant pleural effusions with a chronic indwelling pleural catheter显示文摘van den Toorn LM Schaap E Surmont VF 2005Lung Cancer2005,50,1:1
6A double-blind,randomised,placebo-controlled phaseⅢintergroup study of gefitinib in patients with advanced NSCLC,non-progressing after first line platinum-based chemotherapy(EORTC 08021/ILCP 01/03)显示文摘Gaafar RM Surmont VF Scagliotti GV 0,,:1
7A double- blind, randomised, placebo-controlled phase III inter- group study of gefitinib in patients with advanced NS- CLC,non-progressing after first line platinum-based chemotherapy(EORTC 08021/ILCP 01/03)显示文摘Gaafar R M Surmont V F Scagliotti G V 2011Eur J Cancer2011,47,15:1
8Stage Ⅲ A-N2 NSCLC:a review of its treatmentapproaches and future developments显示文摘van Meerbeeck JP Surmont VF 0,,:1
9Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: results from 2 phase I studies 显示文摘Surmont V Smit EF de Jonge M 2010Lung Cancer2010,69,3:1
10Stage Ⅲ A-N2 NSCLC:a review of its treatment approaches and future developments显示文摘van Meerbeeck JP Surmont VF 0,,:1
11Geomagnetic field intensity between 70 000 and 130 000 years BP from a volcanic sequence on La Reunion,Indian Ocean显示文摘Asmae Rais Carlo Laj Jerome Surmont 1996Earth and Planetary Science Letters1996,140,:1
12Raltitrexed in mesothelioma显示文摘Surmont VF van Meerbeeck JP 2011Ex- pert Rev Anticancer Ther2011,11,10:1
13Raltitrexed in mesothel:oma 显示文摘Surmont VF van Meerbeeck JP 2011Expert Rev Anticancer Ther2011,11,10:1
14Stage IlIA-N2 NSCLC: a review of its treatment approaches and future developments 显示文摘van Meerbeeck JP Surmont VFM 2009Lung Cancer2009,65,3:1
15A doubleblind,randomised,placebo-controlled phaseⅢintergroup study of gefitinib in patients with advanced NSCLC,nonprogressing after first line platinum-based chemotherapy(EORTC 08021/ILCP 01/03)显示文摘Gaafar R M Surmont V F Scagliotti G V 2011Eur J Cancer2011,47,15:1
16A double- blind, randomized,placebo-controlled phase Ⅲ intergroup study of gefitinib in patients with advanced NSCLC on- progressing after first-line platinum-based chemotherapy ( EORTC08021/ILCPO1/03 ) 显示文摘Gaafar RM Surmont VF Scagliotti GV 2011Eur J Cancer2011,47,15:1
17A double- blind, randomised, placebo- controlled phase II1 intergroup study of gefitinib in patients with advanced NSCLC, non- progressing after first line platinum- based chemotherapy (EORTC 08021/ILCP 01/03)显示文摘GAAFAR RM SURMONT VF SCAGLIOTI GV et 01 2011Eur J Cancer2011,47,15:1
18A doubleblind,randomised,placebo-controlled phaseⅢintergroup study of gefitinib in patients with advanced NSCLC,nonprogressing after first line platinum-based chemotherapy(EORTC 08021/ILCP 01/03)显示文摘Gaafar R M Surmont V F Scagliotti G V 2011European Journal of Cancer2011,47,15:1
19Manage-ment of recurrent malignant pleural effusions with a chron-ic indwelling pleural catheter显示文摘Van den Toorn L M Schaap E Surmont V F 2005Lung Cancer2005,50,1:1
20Management of recurrent malignant pleural effusions with a chronic indwelling pleural catheter显示文摘Van den Toora LM Schaap E Surmont VF 2005Lung Cancer2005,50,1:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费